AnaptysBio, Inc. (ANAB) Tops Q4 EPS by 4c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q4 EPS of ($1.59), $0.04 better than the analyst estimate of ($1.63). Revenue for the quarter came in at $0 versus the consensus estimate of $3.83 million.

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Dell shares surge on record AI server bookings
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings